Recently, the Novo Nordisk Foundation updated its strategy to include regenerative medicine. While regenerative medicine is not new to the Foundation, it is now an explicit part of the company’s strategy. DDW’s Megan Thomas caught up with Martin Ridderstråle, Senior Vice President and Head of Medical Science at the Novo Nordisk Foundation, to learn more […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!